Is retinal nerve fibre layer thickness correlated with visual function in individuals having optic neuritis?

The existence of a correlation between the results of paraclinical retinal imaging and clinical tests such as contrast sensitivity can reduce time and cost in diagnosing optic neuritis (ON).

To demonstrate whether changes of peripapillary retinal nerve fibre layer (RNFL) thickness are correlated with the results of visual acuity, contrast sensitivity and colour vision in eyes with acute ON.

Thirty patients with acute ON, 23 females and seven males, who had no previous history of ON in neither eye, were examined. Inclusion criteria were: subjects had spherical refraction of less than ±5D, no prior ON or optic disc swelling, no history of amblyopia or colour blindness, and no history or ophthalmoscopic evidence of glaucoma, diabetic retinopathy, or maculopathies. Visual acuity, contrast sensitivity and colour vision were tested and optical coherence tomography was performed for all patients after complete ophthalmologic examinations including refraction, biomicroscopy, and funduscopy with a 90D lens by a neuro-ophthalmologist.

Thirty patients who were 18-45 years old entered the study. There was an inverse correlation between contrast sensitivity and nasal (r = -0.430, p = 0.018), inferior (r = -0.503, p = 0.005) and mean (r = -0.510, p = 0.004) RNFL thickness. The multiple linear regression model, after adjustment for age and sex, showed a significant association between visual acuity and nasal RNFL thickness (coefficient = 0.025, p = 0.032). There was also a significant inverse correlation between contrast sensitivity and nasal (coefficient = -0.003, p = 0.036), inferior (coefficient = -0.006, p = 0.010) and mean (coefficient = -0.007, p = 0.012) RNFL thickness. No significant correlation was found between colour vision and RNFL thickness.

Contrast sensitivity is more correlated with changes in RNFL thickness in comparison with visual acuity and colour vision. Contrast sensitivity measurement therefore can be used as one of the first assessments in patients with ON.